Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 1:12:209-220.
doi: 10.2147/JBM.S304597. eCollection 2021.

Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers

Richard Gooding  1 , Jecko Thachil  2 , Jayanthi Alamelu  3 , Jayashree Motwani  4 , Pratima Chowdary  5
Affiliations
Review

Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers

Richard Gooding et al. J Blood Med. .

Abstract

Joint health is a key contributor to quality of life in patients with hemophilia. However, variables that impact long-term joint outcomes have not been comprehensively defined. A systematic literature search identified publications relating to joint health in patients with hemophilia. Studies clearly show that early, sustained prophylaxis with factor replacements improves long-term joint outcomes. However, a subset of patients appear to develop arthropathy despite maintaining excellent bleeding outcomes, which suggests possible recurrent asymptomatic bleeding into the joints in these patients. Furthermore, limited data are available on how long-acting factor VIII and factor IX replacement therapies could impact long-term joint outcomes. Many variables were identified as potential indicators that a patient may develop hemophilic arthropathy, including genetic mutations, endogenous factor VIII and IX levels, bone health, and physical activity levels. Tools for the diagnosis and monitoring of hemophilic arthropathy are critical to detect early joint damage, so that management can be adjusted accordingly. Imaging techniques, particularly magnetic resonance imaging, can detect synovial changes, a strong predictor for the future development of hemophilic arthropathy. In addition, several biomarkers associated with cartilage and bone formation, vascularization, and angiogenesis could potentially identify the onset and progression of early joint damage. Since the development of hemophilic arthropathy is complex, a comprehensive therapeutic approach is necessary for the effective prevention of arthropathy in patients with hemophilia.

Keywords: asymptomatic bleeding; hemarthropathy; hemarthrosis; hemophilia; hemophilic arthropathy; joint disease.

PubMed Disclaimer

Conflict of interest statement

Dr Richard Gooding reports personal fees from CSL Behring, during the conduct of the study. Dr Jecko Thachil reports personal fees from CSL Behring, Takeda, Shire, Roche Chugai, and Sobi, during the conduct of the study. Professor Pratima Chowdary reports non-financial support from CSL Behring, during the conduct of the study; grants from and advisory committee for Pfizer, Bayer, CSL Behring, Freeline, Novo Nordisk, Sobi, Chugai, Roche, Takeda, Sanofi, and Spark; personal fees from BioMarin and UniQure, outside the submitted work. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
PRISMA systematic literature review flow chart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. van Vulpen LFD, Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and imaging. Haemophilia. 2018;24(S6):44–49. doi:10.1111/hae.13449 - DOI - PubMed
    1. Rodriguez-Merchan EC. Musculo-skeletal manifestations of haemophilia. Blood Rev. 2016;30(5):401–409. doi:10.1016/j.blre.2016.04.008 - DOI - PubMed
    1. Chen CM, Huang KC, Chen CC, et al. The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study. Haemophilia. 2015;21(3):e176–e184. doi:10.1111/hae.12644 - DOI - PubMed
    1. Holstein K, von Mackensen S, Bokemeyer C, Langer F. The impact of social factors on outcomes in patients with bleeding disorders. Haemophilia. 2016;22(1):46–53. doi:10.1111/hae.12760 - DOI - PubMed
    1. Khair K, Holland M, Bladen M, Griffioen A, McLaughlin P, von Mackensen S. Study of physical function in adolescents with haemophilia: the SO-FIT study. Haemophilia. 2017;23(6):918–925. doi:10.1111/hae.13323 - DOI - PubMed

LinkOut - more resources